Erratum: Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv. 2017;1(25):2343-2347.
Ontology highlight
ABSTRACT: [This corrects the article DOI: 10.1182/bloodadvances.2017012732.].
Erratum: Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. <i>Blood Adv.</i> 2017;1(25):2343-2347.
Blood advances 20180109 1
[This corrects the article DOI: 10.1182/bloodadvances.2017012732.]. ...[more]
Project description:Altered number, subset composition, and function of bone marrow innate lymphoid cells are early events in monoclonal gammopathies.Pomalidomide therapy leads to reduction in Ikzf1 and Ikzf3 and enhanced human innate lymphoid cell function in vivo.